|
|
|
|
| LEADER |
03259nam a2200673 4500 |
| 001 |
ocn694733434 |
| 003 |
OCoLC |
| 005 |
20170124071743.4 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
110103s2011 nyua ob 001 0 eng d |
| 040 |
|
|
|a GW5XE
|b eng
|e pn
|c GW5XE
|d EBLCP
|d OCLCQ
|d MHW
|d OCLCQ
|d OCLCF
|d OCLCQ
|d E7B
|d N$T
|d RRP
|d OCLCO
|d YDXCP
|d DEBSZ
|d OCLCO
|d DG1
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DEBBG
|d DG1
|d GrThAP
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 698589443
|a 748435289
|a 771448200
|a 798698956
|
| 020 |
|
|
|a 9781441972163
|q (electronic bk.)
|
| 020 |
|
|
|a 1441972161
|q (electronic bk.)
|
| 020 |
|
|
|a 9781441972156
|q (electronic bk.)
|
| 020 |
|
|
|a 1441972153
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000048771752
|
| 029 |
1 |
|
|a AU@
|b 000049595547
|
| 029 |
1 |
|
|a DEBSZ
|b 430928793
|
| 029 |
1 |
|
|a GBVCP
|b 790038005
|
| 029 |
1 |
|
|a NZ1
|b 13777845
|
| 029 |
1 |
|
|a NZ1
|b 15921957
|
| 029 |
1 |
|
|a DEBBG
|b BV043392620
|
| 035 |
|
|
|a (OCoLC)694733434
|z (OCoLC)698589443
|z (OCoLC)748435289
|z (OCoLC)771448200
|z (OCoLC)798698956
|
| 037 |
|
|
|a 978-1-4419-7215-6
|b Springer
|n http://www.springerlink.com
|
| 050 |
|
4 |
|a RC280.O8
|b E44 2011
|
| 060 |
|
4 |
|a 2011 B-194
|
| 060 |
|
4 |
|a WP 322
|
| 072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/465
|2 22
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Emerging therapeutic targets in ovarian cancer /
|c Stan Kaye [and others], editors.
|
| 264 |
|
1 |
|a New York :
|b Springer Science+Business Media, LLC,
|c [2011]
|
| 264 |
|
4 |
|c ©2011
|
| 300 |
|
|
|a 1 online resource (xiii, 291 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.
|
| 520 |
|
|
|a This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Ovaries
|x Cancer
|x Treatment.
|
| 650 |
1 |
2 |
|a Ovarian Neoplasms
|x therapy.
|
| 650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use.
|
| 650 |
2 |
2 |
|a Drug Design.
|
| 650 |
2 |
2 |
|a Drug Therapy
|x trends.
|
| 650 |
|
4 |
|a Medicine.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
| 650 |
|
7 |
|a Ovaries
|x Cancer
|x Treatment.
|2 fast
|0 (OCoLC)fst01049287
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Kaye, Stanley B.
|
| 776 |
0 |
8 |
|i Print version:
|t Emerging therapeutic targets in ovarian cancer.
|d New York : Springer, ©2011
|z 9781441972156
|w (OCoLC)702604723
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118185537
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
